May 27, 2018 6:09 AM ET


Company Overview of Civitas Therapeutics, Inc.

Company Overview

Civitas Therapeutics, Inc., a biopharmaceutical company, develops and commercializes transformative therapeutics using its ARCUS technology. Its technology enables the delivery of a precise dose to the lung to potentially enable rapid and predictable L-dopa absorption through a reusable, pocket-size, and breath-actuated inhaler. The company offers CVT-301, a inhaled L-dopa therapy for OFF episodes that provides rapid delivery of L-dopa to the brain to be used in conjunction with a Parkinson’s disease patient’s individually optimized oral L-dopa regimen. Civitas Therapeutics, Inc. was formerly known as Corregidor Therapeutics, Inc. and changed its name to Civitas Therapeutics, Inc. in April 2...

190 Everett Avenue

Chelsea, MA 02150

United States

Founded in 2009





Key Executives for Civitas Therapeutics, Inc.

Co-Founder, Consultant and Director
Age: 55
Co-Founder and Chief Medical Officer
Age: 56
Co-Founder and Chairman of Scientific & Clinical Advisory Board
Age: 69
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Civitas Therapeutics, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at